`
`doi:10.1038/mt.2015.89
`
`© The American Society of Gene & Cell Therapy
`
`Corrigendum to “Chimeric Receptors Containing
`CD137 Signal Transduction Domains Mediate
`Enhanced Survival of T Cells and Increased
`Antileukemic Efficacy In Vivo”
`Michael C. Milone, Jonathan D. Fish, Carmine Carpenito, Richard G. Carroll, Gwendolyn K. Binder,
`David Teachey, Minu Samanta, Mehdi Lakhal, Brian Gloss, Gwenn Danet-Desnoyers, Dario Campana,
`James L. Riley, Stephan A. Grupp and Carl H. June
`
`Molecular Therapy (2009) 17: 1453–1464. doi:10.1038/mt.2009.83
`
`The order of variable heavy (VH) and variable light chain (VL) domains of the anti-CD19 scFv depicted in the schematic of Figure 1a
`were reversed from the actual orientation used. The order of the domains should be VL followed by VH.
`
`doi:10.1038/mt.2015.57
`
`Corrigendum to “Insulin-like Growth Factor-
`binding Protein-7 (IGFBP7): A Promising Gene
`Therapeutic for Hepatocellular Carcinoma (HCC)”
`Dong Chen, Ayesha Siddiq, Luni Emdad, Devaraja Rajasekaran, Rachel Gredler, Xue-Ning Shen,
`Prasanna K Santhekadur, Jyoti Srivastava, Chadia L Robertson, Igor Dmitriev, Elena A Kashentseva,
`David T Curiel, Paul B Fisher and Devanand Sarkar
`
`Molecular Therapy (2013) 21: 758–766. doi:10.1038/mt.2012.282
`
`There was an error in Figure 1b. The correct Figure 1b appears below.
`
`IGFBP7
`
`EF1α
`
`b
`
`Huh7
`
`Hep3B
`
`HepG3
`
`Ad.I7-3d
`Ad.I7-2d
`
`Ad.I7-1d
`
`Ad.vec
`
`Control
`
`Ad.I7-3d
`
`Ad.I7-2d
`
`Ad.I7-1d
`Ad.vec
`Control
`
`Ad.I7-3d
`
`Ad.I7-2d
`
`Ad.I7-1d
`
`Ad.vec
`
`Control
`
`1278
`
`www.moleculartherapy.org vol. 23 no. 7, 1278 jul. 2015
`
`UPenn Ex. 2078
`Miltenyi v. UPenn
`IPR2022-00855
`
`